‘CORRUPTION': Dr. Mehmet Oz highlights the Medicaid fraud battle

CMS Administrator Dr. Mehmet Oz discussed the FDA approval of Rasonque for pancreatic cancer alongside a CMS crackdown on Medicaid fraud. While the fraud enforcement is a negative compliance signal for providers, the cancer drug approval is a clear incremental positive for the healthcare/biotech outlook. Overall, the news reads as cautiously supportive with likely limited market-wide impact.